Search Results - "LORIMER, I. A. J" :: K.UTB vyhledávací portál

Repression of cancer cell senescence by PKCι

by Paget, J A, Restall, I J, Daneshmand, M, Mersereau, J A, Simard, M A, Parolin, D A E, Lavictoire, S J, Amin, M S, Islam, S, Lorimer, I A J
Published in Oncogene (02.08.2012)

Get full text

Journal Article

Loading…

Regulation of glioblastoma cell invasion by PKCι and RhoB

by Baldwin, R M, Parolin, D A E, Lorimer, I A J
Published in Oncogene (05.06.2008)

Get full text

Journal Article

Loading…

Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Cι-mediated attenuation of p38 MAP kinase signaling

by Baldwin, R M, Garratt-Lalonde, M, Parolin, D A E, Krzyzanowski, P M, Andrade, M A, Lorimer, I A J
Published in Oncogene (11.05.2006)

Get full text

Journal Article

Loading…

Mutant epidermal growth factor receptors as targets for cancer therapy

by Lorimer, I A J
Published in Current cancer drug targets (01.06.2002)

Get more information

Journal Article

Loading…

Regulation of glioblastoma cell invasion by PKCi and RhoB

by BALDWIN, R. M, PAROLIN, D. A. E, LORIMER, I. A. J
Published in Oncogene (05.06.2008)

Get full text

Journal Article

Loading…

A phase I study of oral ZD 1839 given daily in patients with solid tumors: IND.122, a study of the Investigational New Drug Program of the National Cancer Institute of Canada Clinical Trials Group

by Goss, G, Hirte, H, Miller, Jr, W H, Lorimer, I A J, Stewart, D, Batist, G, Parolin, D A E, Hanna, P, Stafford, S, Friedmann, J, Walsh, W, Mathews, S, Douglas, L, Seymour, L K
Published in Investigational new drugs (01.01.2005)

Get full text

Journal Article

Loading…

Repression of cancer cell senescence by PKC[iota]

by Paget, J A, Restall, I J, Daneshmand, M, Mersereau, J A, Simard, M A, Parolin, D A E, Lavictoire, S J, Amin, M S, Islam, S, Lorimer, I A J
Published in Oncogene (02.08.2012)

Get full text

Journal Article

Loading…

Regulation of glioblastoma cell invasion by PKC[iota] and RhoB

by Baldwin, R M, Parolin, D A E, Lorimer, I A J
Published in Oncogene (05.06.2008)

Get full text

Journal Article

Loading…

Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase C -mediated attenuation of p38 MAP kinase signaling

by Baldwin, R M, Garratt-Lalonde, M, Parolin, D A E, Krzyzanowski, P M, Andrade, M A, Lorimer, I A J
Published in Oncogene (11.05.2006)

Get full text

Journal Article

Loading…

Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ciota-mediated attenuation of p38 MAP kinase signaling

by Baldwin, R M, Garratt-Lalonde, M, Parolin, D A E, Krzyzanowski, P M, Andrade, M A, Lorimer, I A J
Published in Oncogene (11.05.2006)

Get full text

Journal Article

Loading…

Protection of glioblastoma cells from cisplatin cytotoxicity via protein kinase Ci-mediated attenuation of p38 MAP kinase signaling

by BALDWIN, R. M, GARRATT-LALONDE, M, PAROLIN, D. A. E, KRZYZANOWSKI, P. M, ANDRADE, M. A, LORIMER, I. A. J
Published in Oncogene (2006)

Get full text

Journal Article

Loading…

Regional Treatment of Epidermal Growth Factor Receptor vIII-expressing Neoplastic Meningitis with a Single-Chain Immunotoxin, MR-1

by ARCHER, G. E, SAMPSON, J. H, LORIMER, I. A. J, MCLENDON, R. E, KUAN, C.-T, FRIEDMAN, A. H, FRIEDMAN, H. S, PASTAN, I. H, BIGNER, D. D
Published in Clinical cancer research (01.09.1999)

Get full text

Journal Article

Loading…

Immunotoxins that target an oncogenic mutant epidermal growth factor receptor expressed in human tumors

by LORIMER, I. A. J, WIKSTRAND, C. J, BATRA, S. K, BIGNER, D. D, PASTAN, I
Published in Clinical cancer research (01.08.1995)

Get full text

Journal Article

Loading…

125I-labeled Anti-Epidermal Growth Factor Receptor-vIII Single-Chain Fv Exhibits Specific and High-Level Targeting of Glioma Xenografts

by KUAN, C.-T, REIST, C. J, FOULON, C. F, LORIMER, I. A. J, ARCHER, G, PEGRAM, C. N, PASTAN, I, ZALUTSKY, M. R, BIGNER, D. D
Published in Clinical cancer research (01.06.1999)

Get full text

Journal Article